Associate Director, Portfolio Insights
South San Francisco, CA, United States Hybrid
$141,500–$268,500 a yearJobFig found this opening at its original source and checks that it remains available.
About the role
The Portfolio Insights team is responsible for enabling AbbVie to make data-driven decisions on portfolio choices both within and across Therapeutic Areas (TAs). Core responsibilities include valuation of the internal portfolio, PTRS (probability of technical and regulatory success) assessments, cross-TA prioritization of R&D spend, benchmarking and analytic support for annual financial business processes. The Associate Director, Portfolio Insights drives high-impact strategic projects and provides broad exposure across Portfolio Insights’ core capabilities. Success will position the Associate Director to transition into a longer-term focus area within Portfolio Insights based on strengths and business needs; options include:
What you'll bring
- Bachelor’s degree in a scientific or business field required
- Prior experience in management consulting,
- Exceptional analytical and problem-solving skills, with a deep understanding of Pharma R&D business processes, investment stage-gating, and commercial forecasting.
- Demonstrated success in fast-paced, ambiguous settings
- proven track record of leading complex strategic initiatives without direct authority.
- High level of executive presence
- ability to navigate different functional perspectives, challenge the status quo, and drive enterprise thinking.
- Excellent oral and written communication skills, with the ability to distill complex data into clear, compelling narratives for senior leadership.
- Strong organizational and project management skills, with the ability to drive multiple workstreams simultaneously.
- Preferred years of experience: 6+ with a Bachelor’s, 4+ with a Master’s, or 2+ with a Doctorate.
- advanced degree (e.g., PharmD, PhD, MD, MBA) highly preferred.
- a track record in R&D strategy / portfolio prioritization projects, strongly preferred.